Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
I. E. Elkholi, A. Robert, C. Malouf…·J.-F. Cote
This study identifies Pik3c3 as a vulnerability in dormancy-prone breast cancer cells, showing its inhibition reduces metastasis in preclinical models.
O. Maller, A. P. Drain, A. S. Barrett…·V. M. Weaver
This study shows that inflammation promotes tumor aggression by stimulating stromal cell-dependent collagen crosslinking and stiffening, identifying lysyl hydroxylase two as a biomarker.
Q. Wu, W. Alawi, G. Deblois…·C. H. Arrowsmith
This study shows that GLUT1 inhibition reduces growth of RB1-positive TNBC cells with high glycolytic activity and low OXPHOS, suggesting a therapeutic target in this subset.
A. Orthwein, S. Findlay, J. Heath…·H. Kuasne
This study identifies FAM35A as a novel REV7 effector that promotes NHEJ and restricts HR by limiting DNA end resection at DSBs.